Search Results - Lueff, Sandor

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    The prognostic impact of germline 46/1 haplotype of Janus kinase 2 in cytogenetically normal acute myeloid leukemia

    The prognostic impact of germline 46/1 haplotype of Janus kinase 2 in cytogenetically normal acute myeloid leukemia by NAHAJEVSZKY, Sarolta, ANDRIKOVICS, Hajnalka, LUEFF, Sandor, MATRAI, Zoltan, MEGGYESI, Nora, SINKO, Janos, SIPOS, Andrea, VARKONYI, Andrea, FEKETE, Sandor, TORDAI, Attila, MASSZI, Tamas, BATAI, Arpad, ADAM, Emma, BORS, Andras, CSOMOR, Judit, GOPCSA, Laszlo, KOSZARSKA, Magdalena, KOZMA, Andras, LOVAS, Nora

    Published in Haematologica (Roma)
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Acalabrutinib and its use in the treatment of chronic lymphocytic leukemia

    Acalabrutinib and its use in the treatment of chronic lymphocytic leukemia by Egyed, Miklos, Lueff, Sandor, Borbely, Judit, Illes, Arpad

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    HFE C282Y Mutation as a Genetic Modifier Influencing Disease Susceptibility for Chronic Myeloproliferative Disease

    HFE C282Y Mutation as a Genetic Modifier Influencing Disease Susceptibility for Chronic Myeloproliferative Disease by Andrikovics, Hajnalka, Meggyesi, Nora, Szilvasi, Aniko, Tamaska, Julia, Halm, Gabriella, Lueff, Sandor, Nahajevszky, Sarolta, Egyed, Miklos, Varkonyi, Judit, Mikala, Gabor, Sipos, Andrea, Kalasz, Laszlo, Masszi, Tamas, Tordai, Attila

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Clinical Characteristics of JAK2 V617F Mutation Positive Acute Myeloid Leukemia

    Clinical Characteristics of JAK2 V617F Mutation Positive Acute Myeloid Leukemia by Nahajevszky, Sarolta, Andrikovics, Hajnalka, Matrai, Zoltan, Lovas, Nora, Lueff, Sandor, Masszi, Tamas

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    HFE C282Y Mutation as a Genetic Modifier Influeincing Disease Susceptibility for Chronic Myeloproliferative Disease

    HFE C282Y Mutation as a Genetic Modifier Influeincing Disease Susceptibility for Chronic Myeloproliferative Disease by ANDRIKOVICS, Hajnalka, MEGGYESI, Nora, SIPOS, Andrea, KALASZ, Laszlo, MASSZI, Tamas, TORDAI, Attila, SZILVASI, Aniko, TAMASKA, Julia, HALM, Gabriella, LUEFF, Sandor, NAHAJEVSZKY, Sarolta, EGYED, Miklos, VARKONYI, Judit, MIKALA, Gabor

    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Drugs, gene transfer, signaling factors: a bench to bedside approach to myocardial stem cell therapy

    Drugs, gene transfer, signaling factors: a bench to bedside approach to myocardial stem cell therapy by Vertesaljai, Marton, Piroth, Zsolt, Fontos, Geza, Andreka, Gyorgy, Font, Gusztav, Szantho, Gergely, Lueff, Sandor, Reti, Marienn, Masszi, Tamas, Ablonczy, Laszlo, Juhasz, Eszter D., Simor, Tamas, Turner, Mark S., Andreka, Peter

    Published in Heart failure reviews
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    HFE C282Y Mutation as a Genetic Modifier Influencing Disease Susceptibility for JAK2 V617F Positive Chronic Myeloproliferative Disease

    HFE C282Y Mutation as a Genetic Modifier Influencing Disease Susceptibility for JAK2 V617F Positive Chronic Myeloproliferative Disease by Andrikovics, Hajnalka, Meggyesi, Nora, Szilvasi, Aniko, Tamaska, Julia, Halm, Gabriella, Lueff, Sandor, Nahajevszky, Sarolta, Egyed, Miklos, Varkonyi, Judit, Mikala, Gabor, Sipos, Andrea, Tordai, Attila, Masszi, Tamas

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: